Enveric Biosciences Inc

General ticker "ENVB" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $3.0M

Enveric Biosciences Inc does not follow the US Stock Market performance with the rate: -39.7%.

Estimated limits based on current volatility of 4.1%: low 0.31$, high 0.34$

Factors to consider:

  • Price in estimated range
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [0.68$, 3.75$]
  • 2023-12-31 to 2024-12-30 estimated range: [0.22$, 1.15$]

Financial Metrics affecting the ENVB estimates:

  • Negative: Non-GAAP EPS, $ of -16.45 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -82.66 <= 2.35
  • Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
  • Negative: Industry earnings per price (median), % of -20.11 <= 1.31

Similar symbols

Short-term ENVB quotes

Long-term ENVB plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $5.62MM $64.62MM $27.42MM
Operating Income $-5.62MM $-64.62MM $-27.42MM
Non-Operating Income $-1.25MM $8.19MM $7.46MM
Interest Expense $0.45MM $0.01MM $0.01MM
R&D Expense $0.17MM $4.79MM $8.03MM
Income(Loss) $-6.86MM $-56.43MM $-19.96MM
Taxes $0.00MM $-7.45MM $-1.49MM
Profit(Loss) $-6.86MM $-48.98MM $-18.47MM
Stockholders Equity $3.42MM $22.31MM $14.67MM
Assets $4.10MM $26.72MM $19.55MM
Operating Cash Flow $-3.89MM $-11.46MM $-17.15MM
Capital expenditure $0.04MM $0.86MM $0.58MM
Investing Cash Flow $-0.04MM $2.19MM $-0.58MM
Financing Cash Flow $5.53MM $24.90MM $18.18MM
Earnings Per Share* $-55.50 $-103.69 $-12.77

* EPS are Split Adjusted, recent splits may be reflected with a delay.